Theravance Biopharma Inc

+0.36 (+1.94%)
Earnings Announcements

Theravance Biopharma Q1 Loss Per Share $1.24

Published: 05/04/2021 21:09 GMT
Theravance Biopharma Inc (TBPH) - Theravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update.
Theravance Biopharma Inc - Total Revenue for Q1 2021 Was $14.3 Million, Down $5.6 Million Versus Q1 2020.
Theravance Biopharma Inc - Cash, Cash Equivalents and Marketable Securities Totaled $210.0 Million As of March 31, 2021.
Theravance Biopharma Inc - Qtrly Loss per Share $1.24.
Revenue is expected to be $18.2 Million
Adjusted EPS is expected to be -$0.99

Next Quarter Revenue Guidance is expected to be $47.28 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.